Medtech

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

January 6, 2025

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 18, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

THIS WEEK'S STORIES

Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility

January 21, 2025

Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software

January 27, 2025

Wedgewood Appoints Benjamin Daniels as General Counsel and Chief Compliance Officer

January 21, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software

Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility

Stratasys Launches TrueDent in Europe, Bringing the Benefits of Monolithic Digital Dentures to Dental Labs, Dentists, and Patients

Vetter introduces the next evolution of the V-OVS® syringe closure system

Royal Orthopaedic Hospital Leverages VitVio’s AI-powered Platform to Increase the Efficiency and Safety in Operating Rooms

Most Read

Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software

Olink® Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology

LIB Therapeutics Announces Publication of Phase 3 Study of Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH) in Lancet Diabetes & Endocrinology

Timothy G. Ferris, MD, MPH, Former NHS England and Mass General Executive, Joins Red Cell Partners to Lead Healthcare Practice

EDITOR PICKS

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tasca Therapeutics Launches with $52 Million Series A Financing

THIS WEEK'S STORIES

Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility

Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software

Wedgewood Appoints Benjamin Daniels as General Counsel and Chief Compliance Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US